Recruiting underserved populations to dermatologic research: A systematic review

International Journal of Dermatology

Volumn 50, Issue 4, 2011, Pages 385-395

  Spears, Chaya R ^a   Nolan, Bridgit V ^a   O'Neill, Jenna L ^a   Arcury, Thomas A ^a   Grzywacz, Joseph G ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURAL ANTHROPOLOGY; DERMATOLOGY; ETHNIC GROUP; HUMAN; MEDICAL RESEARCH; POPULATION RESEARCH; REVIEW; SOCIAL STATUS;

BIOMEDICAL RESEARCH; DERMATOLOGY; HUMANS; MEDICALLY UNDERSERVED AREA; PATIENT SELECTION;

EID: 79952764313     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04813.x     Document Type: Review

References (95)

1. Corbie-Smith G, Ammerman AS, Katz ML, et al. Trust, benefit, satisfaction, and burden: a randomized controlled trial to reduce cancer risk through African-American churches. J Gen Intern Med 2003; 18: 531-541.
2. Corbie-Smith G, Viscoli CM, Kernan WN, et al. Influence of race, clinical, and other socio-demographic features on trial participation. J Clin Epidemiol 2003; 56: 304-309.
3. Corbie-Smith G, Thomas SB, Williams MV, et al. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999; 14: 537-546.
4. Hartley D. Rural health disparities, population health, and rural culture. Am J Public Health 2004; 94: 1675-1678.
5. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol 2004; 22: 730-734.
6. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003; 97: 1499-1506.
7. Armstrong K, Calzone K, Stopfer J, et al. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 2000; 9: 1251-1254.
8. Gorkin L, Schron EB, Handshaw K, et al. Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials 1996; 17: 46-59.
9. Bernhardt BA, Tambor ES, Fraser G, et al. Parents' and children's attitudes toward the enrollment of minors in genetic susceptibility research: implications for informed consent. Am J Med Genet A 2003; 116A: 315-323.
10. Jack WJ, Chetty U, Rodger A. Recruitment to a prospective breast conservation trial: why are so few patients randomised? BMJ 1990; 301: 83-85.
11. Tangrea JA, Adrianza ME, Helsel WE. Patients' perceptions on participation in a cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev 1992; 1: 325-330.
12. Braunstein JB, Sherber NS, Schulman SP, et al. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore) 2008; 87: 1-9.
13. Gorelick PB, Harris Y, Burnett B, et al. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS). J Natl Med Assoc 1998; 90: 141-145.
14. Freedman TG. "Why don't they come to Pike Street and ask us"?: Black American women's health concerns. Soc Sci Med 1998; 47: 941-947.
15. Farmer DF, Jackson SA, Camacho F, et al. Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved 2007; 18: 85-99.
16. Moutsiakis DL, Chin PN. Why blacks do not take part in HIV vaccine trials. J Natl Med Assoc 2007; 99: 254-257.
17. Fouad MN, Partridge E, Green BL, et al. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol 2000; 10: S35-S40.
18. Davis DS. Groups, communities, and contested identities in genetic research. Hastings Cent Rep 2000; 30: 38-45.
19. Knoppers BM, Chadwick R. Human genetic research: emerging trends in ethics. Nat Rev Genet 2005; 6: 75-79.
20. Reilly PR, Boshar MF, Holtzman SH. Ethical issues in genetic research: disclosure and informed consent. Nat Genet 1997; 15: 16-20.
21. Sharp RR, Foster MW. Involving study populations in the review of genetic research. J Law Med Ethics 2000; 28 (1): 41-51.
22. Weijer C, Goldsand G, Emanuel EJ. Protecting communities in research: current guidelines and limits of extrapolation. Nat Genet 1999; 23: 275-280.
23. Catz DS, Green NS, Tobin JN, et al. Attitudes about genetics in underserved, culturally diverse populations. Community Genet 2005; 8: 161-172.
24. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Dermatol 2005; 152: 202-216.
25. Chien YH, Hwu WL, Chiang BL. The genetics of atopic dermatitis. Clin Rev Allergy Immunol 2007; 33: 178-190.
26. Freimuth VS, Quinn SC, Thomas SB, et al. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med 2001; 52: 797-808.
27. Gross CP, Filardo G, Mayne ST, et al. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 2005; 103: 483-491.
28. Jandorf L, Fatone A, Borker PV, et al. Creating alliances to improve cancer prevention and detection among urban medically underserved minority groups. The East Harlem Partnership for Cancer Awareness. Cancer 2006; 107: 2043-2051.
29. McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol 1999; 17: 1029-1039.
30. Marshall PA, Adebamowo CA, Adeyemo AA, et al. Voluntary participation and informed consent to international genetic research. Am J Public Health 2006; 96: 1989-1995.
31. Buchbinder SP, Metch B, Holte SE, et al. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 2004; 36: 604-612.
32. Roberson NL. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 1994; 74: 2687-2691.
33. Harris Y, Gorelick PB, Samuels P, et al. Why African Americans may not be participating in clinical trials. J Natl Med Assoc 1996; 88: 630-634.
34. Katz RV, Green BL, Kressin NR, et al. Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow-up study using the Tuskegee Legacy Project Questionnaire. J Natl Med Assoc 2007; 99: 1052-1060.
35. Dlugos DJ, Scattergood TM, Ferraro TN, et al. Recruitment rates and fear of phlebotomy in pediatric patients in a genetic study of epilepsy. Epilepsy Behav 2005; 6: 444-446.
36. Robinson SB, Ashley M, Haynes MA. Attitude of African-Americans regarding prostate cancer clinical trials. J Community Health 1996; 21: 77-87.
37. Royal C, Baffoe-Bonnie A, Kittles R, et al. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol 2000; 10: S68-S77.
38. Katz RV, Kegeles SS, Kressin NR, et al. Awareness of the Tuskegee Syphilis Study and the US presidential apology and their influence on minority participation in biomedical research. Am J Public Health 2008; 98: 1137-1142.
39. Strauss RP, Sengupta S, Kegeles S, et al. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr 2001; 26: 63-71.
40. Gadegbeku CA, Stillman PK, Huffman MD, et al. Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension. Contemp Clin Trials 2008; 29: 837-842.
41. Smith YR, Johnson AM, Newman LA, et al. Perceptions of clinical research participation among African American women. J Womens Health (Larchmt) 2007; 16: 423-428.
42. Rimer BK, Schildkraut JM, Lerman C, et al. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium. Cancer 1996; 77: 2348-2355.
43. Lichtenberg PA, Brown DR, Jackson JS, et al. Normative health research experiences among African American elders. J Aging Health 2004; 16: 78S-92S.
44. Sengupta S, Strauss RP, DeVellis R, et al. Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr 2000; 24: 275-284.
45. Bryant Borders AE, Grobman WA, Amsden LB, et al. Factors that influence the acceptability of collecting in-home finger stick blood samples in an urban, low-income population. J Health Care Poor Underserved 2007; 18: 100-115.
46. Lara PN Jr, Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 2005; 23: 9282-9289.
47. Williams IC, Corbie-Smith G. Investigator beliefs and reported success in recruiting minority participants. Contemp Clin Trials 2006; 27: 580-586.
48. Fowler BA. An outsider's experiences in conducting field research in an African-American community. J Natl Black Nurses Assoc 2002; 13: 31-37.
49. Pinto HA, Caskill-Stevens W, Wolfe P, et al. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) initiative. Ann Epidemiol 2000; 10: S78-S84.
50. Bates BR, Harris TM. The Tuskegee Study of Untreated Syphilis and public perceptions of biomedical research: a focus group study. J Natl Med Assoc 2004; 96: 1051-1064.
51. Ard JD, Durant RW, Edwards LC, et al. Perceptions of African-American culture and implications for clinical trial design. Ethn Dis 2005; 15: 292-299.
52. Hamilton LA, Aliyu MH, Lyons PD, et al. African-American community attitudes and perceptions toward schizophrenia and medical research: an exploratory study. J Natl Med Assoc 2006; 98: 18-27.
53. Lambert H, McKevitt C. Anthropology in health research: from qualitative methods to multidisciplinarity. BMJ 2002; 325: 210-213.
54. Morse EV, Simon PM, Besch CL, et al. Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res 1995; 8: 8-14.
55. Whelton PK, Lee JY, Kusek JW, et al. Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Control Clin Trials 1996; 17: 17S-33S.
56. National Cancer Institute. Simplification of informed consent documents. 8-19-2009. Available at: (accessed July 26th, 2010).
57. Quandt SA, Doran AM, Rao P, et al. Reporting pesticide assessment results to farmworker families: development, implementation, and evaluation of a risk communication strategy. Environ Health Perspect 2004; 112: 636-642.
58. Geertz C. The Javanese kijaji: the changing role of a cultural broker. 2009; 2 (02): 228-249.
59. Jezewski MA. Evolution of a grounded theory: conflict resolution through culture brokering. ANS Adv Nurs Sci 1995; 17: 14-30.
60. Leung MW, Yen IH, Minkler M. Community based participatory research: a promising approach for increasing epidemiology's relevance in the 21st century. Int J Epidemiol 2004; 33: 499-506.
61. Brody JG, Morello-Frosch R, Brown P, et al. Improving disclosure and consent: "is it safe?": new ethics for reporting personal exposures to environmental chemicals. Am J Public Health 2007; 97: 1547-1554.
62. Morello-Frosch R, Brody JG, Brown P, et al. Toxic ignorance and right-to-know in biomonitoring results communication: a survey of scientists and study participants. Environ Health 2009; 8: 6.
63. Agar MH. The Professional Stranger: An Informal Introduction to Ethnography. San Diego: Academic Press, 2009.
64. Bernard H. Research Methods in Anthropology: Qualitative and Quantitative Methods. Oxford: AltaMira Press, 2009.
65. LeCompte MD, Goetz JP. Problems of reliability and validity in ethnographic research. Rev Educ Res 2009; 52: 31-60.
66. Parker R, Ehrhardt AA. Through an ethnographic lens: ethnographic methods, comparative analysis, and HIV/AIDS research. AIDS and Behavior 2009; 5 (2): 105-114.
67. Wolcott H. On ethnographic intent. In: Spindler GD, Spindler LS, eds. Interpretive Ethnography of Education: At Home and Abroad. Hillsdale, NJ: Erlbaum Associates, 2009.
68. Halbert CH, Gandy OH Jr, Collier A, et al. Intentions to participate in genetics research among African American smokers. Cancer Epidemiol Biomarkers Prev 2006; 15: 150-153.
69. Shavers VL, Lynch CF, Burmeister LF. Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies. J Natl Med Assoc 2000; 92: 563-572.
70. Boulware LE, Cooper LA, Ratner LE, et al. Race and trust in the health care system. Public Health Rep 2003; 118: 358-365.
71. Corbie-Smith G, Thomas SB, St George DM. Distrust, race, and research. Arch Intern Med 2002; 162: 2458-2463.
72. Katz RV, Green BL, Kressin NR, et al. The legacy of the Tuskegee Syphilis Study: assessing its impact on willingness to participate in biomedical studies. J Health Care Poor Underserved 2008; 19: 1168-1180.
73. Moorman PG, Skinner CS, Evans JP, et al. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 2004; 13: 1349-1354.
74. Mouton CP, Harris S, Rovi S, et al. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc 1997; 89: 721-727.
75. Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist 2003; 43: 62-72.
76. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 2002; 12: 248-256.
77. Sugarman J, Kass NE, Goodman SN, et al. What patients say about medical research. IRB 1998; 20: 1-7.
78. Gross D, Julion W, Fogg L. What motivates participation and dropout among low-income urban families of color in a prevention intervention? Fam Relat 2001; 50: 246-254.
79. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002; 20: 2109-2117.
80. Simon MS, Du W, Flaherty L, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 2004; 22: 2046-2052.
81. Outlaw FH, Bourjolly JN, Barg FK. A study on recruitment of black Americans into clinical trials through a cultural competence lens. Cancer Nurs 2000; 23: 444-451.
82. Shavers VL, Lynch CF, Burmeister LF. Factors that influence African-Americans' willingness to participate in medical research studies. Cancer 2001; 91: 233-236.
83. Powell JH, Fleming Y, Walker-McGill CL, et al. The project IMPACT experience to date: increasing minority participation and awareness of clinical trials. J Natl Med Assoc 2008; 100: 178-187.
84. Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc 2005; 97: 951-956.
85. Katz RV, Kegeles SS, Kressin NR, et al. The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research. J Health Care Poor Underserved 2006; 17: 698-715.
86. Audrain J, Tercyak KP, Goldman P, et al. Recruiting adolescents into genetic studies of smoking behavior. Cancer Epidemiol Biomarkers Prev 2002; 11: 249-252.
87. Lamvu G, Lorenz C, Jonsson FM, et al. Racial differences among reasons for participating in research of pregnancy outcomes: the right from the start experience. Gender Med 2005; 2: 166-173.
88. Moore ML. Recruitment and retention: nursing research among low-income pregnant women. Appl Nurs Res 1997; 10: 152-158.
89. Kressin NR, Meterko M, Wilson NJ. Racial disparities in participation in biomedical research. J Natl Med Assoc 2000; 92: 62-69.
90. Zhu K, Hunter S, Bernard LJ, et al. Recruiting elderly African-American women in cancer prevention and control studies: a multifaceted approach and its effectiveness. J Natl Med Assoc 2000; 92: 169-175.
91. Moorman PG, Newman B, Millikan RC, et al. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999; 9: 188-195.
92. Thompson EE, Neighbors HW, Munday C, et al. Recruitment and retention of African American patients for clinical research: an exploration of response rates in an urban psychiatric hospital. J Consult Clin Psychol 1996; 64: 861-867.
93. Moinpour CM, Atkinson JO, Thomas SM, et al. Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 2000; 10: S85-S91.
94. Stoy DB, Curtis RC, Dameworth KS, et al. The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. Cholesterol Reduction in Seniors Program. J Natl Med Assoc 1995; 87: 280-287.
95. Sutherland HJ, da Cunha R, Lockwood GA, et al. What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials? Med Decis Making 1998; 18: 61-69.